34. Neurofibromatosis Clinical trials / Disease details


Clinical trials : 133 Drugs : 186 - (DrugBank : 67) / Drug target genes : 79 - Drug target pathways : 190

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05521048
(ClinicalTrials.gov)
September 19, 202226/8/2022Doxycycline in Cutaneous Schwannoma (NF2)Doxycycline Injection of Cutaneous Schwannoma in Neurofibromatosis Type 2Neurofibromatosis Type 2Drug: Doxycycline Injection [Doxy]Massachusetts Eye and Ear InfirmaryNULLRecruiting8 YearsN/AAll19Phase 1/Phase 2United States